| 000 | 05038cam a2200457Ii 4500 | ||
|---|---|---|---|
| 999 |
_c96427 _d96427 _x1 |
||
| 001 | 96427 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112753.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 170815t20172017sz a ob 001 0 eng d | ||
| 020 |
_a3319573136 _q(electronic bk.) |
||
| 020 |
_a9783319573137 _q(electronic bk.) |
||
| 020 |
_z331957311X _q(hardcover : alk. paper) |
||
| 020 |
_z9783319573113 _q(hardcover : alk. paper) |
||
| 040 |
_aYDX _beng _cYDX _dMMU _dN$T _dOCLCO _dGW5XE _dEBLCP _dN$T _dYDX _dUAB _dUPM _dMERER _dOCLCQ _dESU _dIOG _dNJR _dCOO _dOCLCQ _dOCLCO _dTFH _dOCLCO _dJG0 _dOCLCO _dOCLCQ _dOCLCO _dES-MaUEC _bspa |
||
| 050 | 4 |
_aQH603.M5 _b2017 EB |
|
| 245 | 0 | 0 |
_aPharmacology of mitochondria _cHarpreet Singh, Shey-Shing Sheu, editors. |
| 264 | 1 |
_aCham, Switzerland _bSpringer International Publishing _c2017 |
|
| 264 | 4 | _c2017 | |
| 300 |
_a1 recurso en línea (xi, 493 páginas) _bilustraciones |
||
| 336 |
_astill image _bsti _2rdacontent |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 |
_aHandbook of experimental pharmacology _x1865-0325 _vvolume 240 |
|
| 500 | _a | ||
| 504 | _aIncluye referencias bibliográficas e índice | ||
| 505 | 0 | _aNuclear transcription factors in the mitochondria: a new paradigm in fine-tuning mitochondrial metabolism / Naresh Babu V. Sepuri, Prasad Tammineni, Fareed Mohammed, Arunkumar Paripati -- The mitochondrial permeability transition pore and atp synthase / Gisela Beutner, Kambiz N. Alavian, Elizabeth A. Jonas, George A. Porter Jr -- The roles of mitochondrial cation channels under physiological conditions and in cancer / Ildikò Szabò, Luigi Leanza -- Anion channels of mitochondria / Devasena Ponnalagu, Harpreet Singh -- Guide to the pharmacology of mitochondrial potassium channels / Bartłomiej Augustynek, Wolfram S. Kunz, Adam Szewczyk -- The mitochondrial Ca2+ uniporter: structure, function, and pharmacology / Jyotsna Mishra, Bong Sook Jhun, Stephen Hurst, Jin O-Uchi, Gy̲örgy Csordás [and others] -- Mitochondrial fission in human diseases / Madhavika N. Serasinghe, Jerry E. Chipuk -- Mitochondrial cholesterol and the paradox in cell death / Carmen García-Ruiz, Vicente Ribas, Anna Baulies, Jose C. Fernández-Checa -- Mitochondrial changes in cancer / Shubha Gururaja Rao -- The emerging role of mitochondrial targeting in kidney disease / Alfonso Eirin, Amir Lerman, Lilach O. Lerman -- Mitochondrial dynamics as a therapeutic target for treating cardiac diseases / Sang-Bing Ong, Derek J. Hausenloy -- Mitochondria in Alzheimer's disease and diabetes-associated neurodegeneration: license to heal! / Susana M. Cardoso, Sónia C. Correia, Cristina Carvalho, Paula I. Moreira -- Leber hereditary optic neuropathy: a mitochondrial disease unique in many ways / Rui Bi, Ian Logan, Yong-Gang Yao -- Leber hereditary optic neuropathy: exemplar of an mtdna disease / Douglas C. Wallace, Marie T. Lott -- Equipping physiologists with an informatics tool chest: toward an integerated mitochondrial phenome / Anders Olav Garlid, Jennifer S. Polson, Keith D. Garlid, Henning Hermjakob, Peipei Ping -- Mitochondrial flashes: elemental signaling events in eukaryotic cells / Gaomin Feng, Beibei Liu, Tingting Hou, Xianhua Wang, Heping Cheng -- Mitochondria-targeted agents: mitochondriotropics, mitochondriotoxics, and mitocans / Diana Guzman-Villanueva, Volkmar Weissig -- Role of mitochondrial reactive oxygen species in the activation of cellular signals, molecules, and function / Hiroko P. Indo, Clare L. Hawkins, Ikuo Nakanishi, Ken-ichiro Matsumoto, Hirofumi Matsui [and others] -- Mito-porter for mitochondrial delivery and mitochondrial functional analysis / Yuma Yamada, Hideyoshi Harashima -- Toxicity of antiepileptic drugs to mitochondria / Josef Finsterer. | |
| 520 | 3 | _a"This special book is conceived to highlight mitochondrial structural and functional integrity and how they are associated with several human diseases such as cardiovascular, cancer, renal, neurological disorder, and genetic disorders. The chapters contributed by leading mitochondrial researchers in the handbook will take us through the novel pharmacological strategies via mitochondria to understand their physiological and pathological role as well as present them as therapeutic targets"--Publisher's description. | |
| 588 | _aDescription based on online resource; title from resource home page (SpringerLink, viewed August 16, 2017). | ||
| 988 | _aEBOOK, EBSPRINGER_2017 | ||
| 650 | 7 |
_2embne _9147980 _aMitocondrias |
|
| 650 | 7 |
_2embne _aCitología _9139477 |
|
| 700 | 0 |
_aSingh, Harpreet _c(Pharmacologist), _eeditor literario |
|
| 700 | 1 |
_aSheu, Shey-shing, _eeditor literario |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-57313-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b02/2018 _dz _e- _zSI |
||